Northern Trust Corp Provention Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $126,596 - $457,447	18,895 Added 3.04%	641,249 $15.5 Million
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $258,959 - $605,576	57,292 Added 10.14%	622,354 $6.58 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $164,399 - $269,366	47,930 Added 9.27%	565,062 $2.54 Million
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $16,114 - $32,229	-4,415 Reduced 0.85%	517,132 $2.07 Million
Q1 2022 May 13, 2022	SELL	$3.4 - $7.88 $62,138 - $144,014	-18,276 Reduced 3.39%	521,547 $3.82 Million
Q4 2021 Feb 08, 2022	SELL	$5.59 - $7.39 $147,475 - $194,962	-26,382 Reduced 4.66%	539,823 $3.03 Million
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $36,212 - $53,295	-6,398 Reduced 1.12%	566,205 $3.62 Million
Q2 2021 Aug 13, 2021	SELL	$6.71 - $11.04 $167,602 - $275,757	-24,978 Reduced 4.18%	572,603 $4.83 Million
Q1 2021 May 12, 2021	BUY	$10.12 - $19.45 $197,896 - $380,344	19,555 Added 3.38%	597,581 $6.27 Million
Q4 2020 Feb 11, 2021	SELL	$11.79 - $18.94 $146,089 - $234,685	-12,391 Reduced 2.1%	578,026 $9.79 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $3.93 Million - $5.78 Million	380,366 Added 181.08%	590,417 $7.58 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $1.08 Million - $2.36 Million	138,823 Added 194.9%	210,051 $2.97 Million
Q1 2020 May 14, 2020	BUY	$5.42 - $17.75 $22,216 - $72,757	4,099 Added 6.11%	71,228 $655,000
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $98,520 - $251,363	16,870 Added 33.57%	67,129 $1 Million
Q3 2019 Nov 13, 2019	BUY	$6.83 - $13.0 $135,309 - $257,543	19,811 Added 65.07%	50,259 $343,000
Q2 2019 Aug 13, 2019	BUY	$2.3 - $13.79 $70,030 - $419,877	30,448 New	30,448 $368,000

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account